Elderly men with prostate cancer appeared more likely to be diagnosed with Alzheimer’s disease or dementia if treated with androgen deprivation therapy, according to study results published in JAMA Network Open.
“Studies using national samples have reported conflicting results regarding the diagnosis of Alzheimer’s disease or dementia among older patients with prostate cancer exposed to ADT,” Ravishankar Jayadevappa, PhD, research associate professor at Perelman School of Medicine at University of Pennsylvania, and colleagues wrote.